Cargando…

AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways

Glioma is an intracranial malignant tumor with high morbidity in China. Limited efficacy has been achieved in the treatment of glioma through the application of epidermal growth factor receptor (EGFR) inhibitors, which is reported to be related to the poor permeability of the brain–blood barrier (BB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Wei, Zhang, Ke, Deng, Qinghua, Yu, Qingqing, Mao, Yanjiao, Zhao, Ruping, Ma, Shenglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806996/ https://www.ncbi.nlm.nih.gov/pubmed/34635007 http://dx.doi.org/10.1080/21655979.2021.1991160

Ejemplares similares

AZD3759 enhances radiation effects in non-small-cell lung cancer by a synergistic blockade of epidermal growth factor receptor and Janus kinase-1
por: Zhao, Ruing, et al.
Publicado: (2021)

Determination and pharmacokinetic study of AZD‐3759 in rat plasma by ultra performance liquid chromatography with triple quadrupole mass spectrometer
por: Wu, Qingjun, et al.
Publicado: (2018)

MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling
por: Mao, Yanjiao, et al.
Publicado: (2016)

Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial
por: Maggie Liu, Si-Yang, et al.
Publicado: (2023)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade
por: Martin, Janet L., et al.
Publicado: (2017)

Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)

A case report of toxic epidermal necrolysis associated with AZD-9291
por: Wang, Jie, et al.
Publicado: (2018)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization
por: Gee, Julia MW, et al.
Publicado: (2003)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer
por: Gao, Jin-Hang, et al.
Publicado: (2015)

Redox regulation of Janus kinase: The elephant in the room
por: Duhé, Roy J
Publicado: (2013)

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
por: Veale, Douglas J, et al.
Publicado: (2019)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Janus kinase inhibitors for the therapy of atopic dermatitis
por: Traidl, Stephan, et al.
Publicado: (2021)

Role of Janus Kinase Inhibitors in Therapy of Psoriasis
por: Słuczanowska-Głąbowska, Sylwia, et al.
Publicado: (2021)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Structural basis of Janus kinase trans-activation
por: Caveney, Nathanael A., et al.
Publicado: (2023)

Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease
por: Huo, Rongxiu, et al.
Publicado: (2022)

Author Correction: Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer
por: Gao, Jin-Hang, et al.
Publicado: (2022)

Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors
por: Knight, Emily A., et al.
Publicado: (2015)

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: De Vries, L.C.S., et al.
Publicado: (2017)

Role of janus kinase inhibitors in the treatment of alopecia areata
por: Triyangkulsri, Korn, et al.
Publicado: (2018)

Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
por: Hammitzsch, Ariane, et al.
Publicado: (2020)

Targeting the Janus Kinase Family in Autoimmune Skin Diseases
por: Howell, Michael D., et al.
Publicado: (2019)

Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
por: Li, Boheng, et al.
Publicado: (2021)

Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
por: Qi, Fei, et al.
Publicado: (2021)

Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
por: Nash, David, et al.
Publicado: (2022)

Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases
por: Núñez, Paulina, et al.
Publicado: (2023)

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
por: Singer, Jack W, et al.
Publicado: (2016)

Prognostic significance of epidermal growth factor receptor expression in glioma patients
por: Li, Junhong, et al.
Publicado: (2018)

The expression and prognostic value of the epidermal growth factor receptor family in glioma
por: Xu, Bin, et al.
Publicado: (2021)

Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
por: Paranthaman, Sathishbabu, et al.
Publicado: (2020)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Allosteric regulation of the epidermal growth factor receptor kinase
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_otd9k2f4jpr82aff6eo5111593